Anthony Suchoski, MD
Sleep Medicine · Cincinnati, OHNPI 1285838201
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (53.3%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Idorsia Pharmaceuticals US Inc at 37.1% of the total. Reporting peaked in 2023 at $39,063 and has fallen 88.2% since, to $4,625 in 2025. Among sleep medicine clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 611 payments — averaging $146.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Idorsia Pharmaceuticals US Inc$33K
- Axsome Therapeutics, Inc.$23K
- Harmony Biosciences LLC$16K
- Jazz Pharmaceuticals Inc.$11K
- ZOLL Respicardia, Inc.$2K
- Inspire Medical Systems, Inc.$864
- plus $3K from 14 others
What the payments were for
- Consulting fees$21,32724%
- Speaking & faculty fees$47,63853%
- Travel & lodging$5,9027%
- Food & beverage$14,15116%
- Education$2800%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Idorsia Pharmaceuticals US Inc | 59 | $33,101 |
| Axsome Therapeutics, Inc. | 64 | $23,163 |
| Harmony Biosciences LLC | 202 | $15,985 |
| Jazz Pharmaceuticals Inc. | 128 | $11,461 |
| ZOLL Respicardia, Inc. | 5 | $2,044 |
| Inspire Medical Systems, Inc. | 23 | $864 |
| Avadel CNS Pharmaceuticals, LLC | 19 | $620 |
| Merck | 27 | $405 |
| Eisai Inc. | 31 | $318 |
| Fisher & Paykel Healthcare Inc | 10 | $232 |
| Vanda Pharmaceuticals Inc. | 13 | $202 |
| Novo Nordisk | 5 | $194 |
| Lilly USA, LLC | 5 | $187 |
| GSK | 6 | $186 |
| Lucid Diagnostics Inc. | 1 | $115 |
| Resmed Corp | 5 | $76 |
| Sanofi | 2 | $57 |
| Arbor Pharmaceuticals, Inc. | 3 | $38 |
| 3b Medical, Inc. | 2 | $28 |
| Itamar Medical Inc | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$89,298 in reported general payments places this provider in the 95th percentile of 94 sleep medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sodium Oxybate | 11 | $210,175 |
| WakixPitolisant Hcl | 27 | $176,554 |
| BelsomraSuvorexant | 46 | $27,983 |
| SunosiSolriamfetol Hcl | 18 | $18,847 |
| NuvigilArmodafinil | 11 | $11,482 |
| Modafinil | 45 | $5,516 |
| Armodafinil | 18 | $2,367 |
| Zaleplon | 40 | $1,045 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 24 | $822 |
| Ropinirole Hcl | 29 | $678 |
| Methylphenidate Hcl | 36 | $518 |
| Zolpidem Tartrate | 55 | $357 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 22 | $295 |
| Trazodone Hcl | 39 | $220 |
| Eszopiclone | 11 | $200 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Harmony Biosciences LLCWakix | $15,985 | $176,55427 claims |
| MerckBelsomra | $405 | $27,98346 claims |
| Axsome Therapeutics, Inc.Sunosi | $23,163 | $18,84718 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 94 sleep medicine providers in Ohio.
Other sleep medicine in Cincinnati
- Shahrokh JavaheriCincinnati$404K
- Shayla PullenCincinnati$71K
- Sunil DamaCincinnati$7K
- Omdevasena ThirugnanamCincinnati$7K
- Karthikeyan KanagarajanCincinnati$6K
- Chiranjeevi Pramodna SiddaguntaCincinnati$3K
- Bashar BrijawiCincinnati$3K
- Ann RomakerCincinnati$2K
- Roma UyCincinnati$1K
- Asim RoyDublin$666K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.